191 related articles for article (PubMed ID: 37312934)
21. Preparation and characterization of photo-responsive cell-penetrating peptide-mediated nanostructured lipid carrier.
Yang Y; Yang Y; Xie X; Cai X; Mei X
J Drug Target; 2014 Dec; 22(10):891-900. PubMed ID: 25045925
[TBL] [Abstract][Full Text] [Related]
22. Lipoprotein-Inspired Nanocarrier Composed of Folic Acid-Modified Protein and Lipids: Preparation and Evaluation of Tumor-Targeting Effect.
Han M; Ji X; Li J; Ge Z; Luo B; Zhou K; Wang Q; Sun X; Zhang W; Li J
Int J Nanomedicine; 2020; 15():3433-3445. PubMed ID: 32523342
[TBL] [Abstract][Full Text] [Related]
23. Near-infrared mediated quantum dots and paclitaxel co-loaded nanostructured lipid carriers for cancer theragnostic.
Olerile LD; Liu Y; Zhang B; Wang T; Mu S; Zhang J; Selotlegeng L; Zhang N
Colloids Surf B Biointerfaces; 2017 Feb; 150():121-130. PubMed ID: 27907859
[TBL] [Abstract][Full Text] [Related]
24. Calcitriol-Loaded Dual-pH-Sensitive Micelle Counteracts Pro-Metastasis Effect of Paclitaxel in Triple-Negative Breast Cancer Therapy.
Zheng Z; Lang T; Huang X; Wang G; Lee RJ; Teng L; Yin Q; Li Y
Adv Healthc Mater; 2020 Jun; 9(12):e2000392. PubMed ID: 32419319
[TBL] [Abstract][Full Text] [Related]
25. Stereocomplex micelle loaded with paclitaxel for enhanced therapy of breast cancer in an orthotopic mouse model.
Piao L; Li Y; Zhang H; Jiang J
J Biomater Sci Polym Ed; 2019 Feb; 30(3):233-246. PubMed ID: 30606090
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, characterization and radiolabeling of folic acid modified nanostructured lipid carriers as a contrast agent and drug delivery system.
Ucar E; Teksoz S; Ichedef C; Kilcar AY; Medine EI; Ari K; Parlak Y; Sayit Bilgin BE; Unak P
Appl Radiat Isot; 2017 Jan; 119():72-79. PubMed ID: 27866122
[TBL] [Abstract][Full Text] [Related]
27. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
[TBL] [Abstract][Full Text] [Related]
28. Development and optimization of transferrin-conjugated nanostructured lipid carriers for brain delivery of paclitaxel using Box-Behnken design.
Emami J; Rezazadeh M; Sadeghi H; Khadivar K
Pharm Dev Technol; 2017 May; 22(3):370-382. PubMed ID: 27689412
[TBL] [Abstract][Full Text] [Related]
29. Leukocyte-mimicking Pluronic-lipid nanovesicle hybrids inhibit the growth and metastasis of breast cancer.
Chen Q; Chen Y; Sun Y; He W; Han X; Lu E; Sha X
Nanoscale; 2019 Mar; 11(12):5377-5394. PubMed ID: 30849160
[TBL] [Abstract][Full Text] [Related]
30. Reversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cells.
Zhang XG; Miao J; Dai YQ; Du YZ; Yuan H; Hu FQ
Int J Pharm; 2008 Sep; 361(1-2):239-44. PubMed ID: 18586075
[TBL] [Abstract][Full Text] [Related]
31. Redox sensitive PEG controlled octaarginine and targeting peptide co-modified nanostructured lipid carriers for enhanced tumour penetrating and targeting in vitro and in vivo.
Wang H; Sun M; Li D; Yang X; Han C; Pan W
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):313-322. PubMed ID: 28362124
[TBL] [Abstract][Full Text] [Related]
32. Preparation Of Nanobubbles Modified With A Small-Molecule CXCR4 Antagonist For Targeted Drug Delivery To Tumors And Enhanced Ultrasound Molecular Imaging.
Peng Y; Zhu L; Wang L; Liu Y; Fang K; Lan M; Shen D; Liu D; Yu Z; Guo Y
Int J Nanomedicine; 2019; 14():9139-9157. PubMed ID: 32063704
[TBL] [Abstract][Full Text] [Related]
33. Dual-function nanostructured lipid carriers to deliver IR780 for breast cancer treatment: Anti-metastatic and photothermal anti-tumor therapy.
Li H; Wang K; Yang X; Zhou Y; Ping Q; Oupicky D; Sun M
Acta Biomater; 2017 Apr; 53():399-413. PubMed ID: 28159715
[TBL] [Abstract][Full Text] [Related]
34. Photo-responsive and NGR-mediated multifunctional nanostructured lipid carrier for tumor-specific therapy.
Yang Y; Xie X; Yang Y; Zhang H; Mei X
J Pharm Sci; 2015 Apr; 104(4):1328-39. PubMed ID: 25630979
[TBL] [Abstract][Full Text] [Related]
35.
Gibbens-Bandala B; Morales-Avila E; Ferro-Flores G; Santos-Cuevas C; Meléndez-Alafort L; Trujillo-Nolasco M; Ocampo-García B
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110043. PubMed ID: 31546458
[TBL] [Abstract][Full Text] [Related]
36. Novel biomimetic nanostructured lipid carriers for cancer therapy: preparation, characterization, and
Zhou J; Guo B; Zhu W; Sui X; Ma X; Qian J; Cao L; Han C
Pharm Dev Technol; 2021 Jan; 26(1):81-91. PubMed ID: 33070668
[TBL] [Abstract][Full Text] [Related]
37. Folate Modified Long Circulating Nano-Emulsion as a Promising Approach for Improving the Efficiency of Chemotherapy Drugs in Cancer Treatment.
Song B; Wu S; Li W; Chen D; Hu H
Pharm Res; 2020 Nov; 37(12):242. PubMed ID: 33188481
[TBL] [Abstract][Full Text] [Related]
38. A neutrophil-mediated carrier regulates tumor stemness by inhibiting autophagy to prevent postoperative triple-negative breast cancer recurrence and metastasis.
Ren K; He J; Qiu Y; Xu Z; Wang X; Li J; Zang S; Yang Y; Li J; Long Y; Zhang Z; Li M; He Q
Acta Biomater; 2022 Jun; 145():185-199. PubMed ID: 35447368
[TBL] [Abstract][Full Text] [Related]
39. Multifunctional Liposomes Enable Active Targeting and Twinfilin 1 Silencing to Reverse Paclitaxel Resistance in Brain Metastatic Breast Cancer.
Du J; Shao Y; Hu Y; Chen Y; Cang J; Chen X; Pei W; Miao F; Shen Y; Muddassir M; Zhang Y; Zhang J; Teng G
ACS Appl Mater Interfaces; 2021 May; 13(20):23396-23409. PubMed ID: 33982563
[TBL] [Abstract][Full Text] [Related]
40. Paclitaxel-loaded Nanolipidic Carriers with Improved Oral Bioavailability and Anticancer Activity against Human Liver Carcinoma.
Harshita ; Barkat MA; Rizwanullah M; Beg S; Pottoo FH; Siddiqui S; Ahmad FJ
AAPS PharmSciTech; 2019 Jan; 20(2):87. PubMed ID: 30675689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
